The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ
Open Access
- 18 June 2008
- journal article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 6 (1), 61
- https://doi.org/10.1186/1477-7819-6-61
Abstract
Debate regarding the benefit of radiotherapy after local excision of ductal carcinoma in situ (DCIS) continues. The Van Nuys Prognostic Index (VNPI) is thought to be a useful aid in deciding which patients are at increased risk of local recurrence and who may benefit from adjuvant radiotherapy (RT). Recently published interim data from the Sloane project has showed that the VNPI score did significantly affect the chances of getting planned radiotherapy in the UK, suggesting that British clinicians may already be using this scoring system to assist in decision making. This paper independently assesses the prognostic validity of the VNPI in a British population. A retrospective review was conducted of all patients (n = 215) who underwent breast conserving surgery for DCIS at a single institution between 1997-2006. No patients included in the study received additional radiotherapy or hormonal treatment. Kaplan Meier survival curves were calculated, to determine disease free survival, for the total sample and a series of univariate analyses were performed to examine the value of various prognostic factors including the VNPI. The log-rank test was used to determine statistical significance of differential survival rates. Multivariate Cox regression analysis was performed to analyze the significance of the individual components of the VNPI. All analyses were conducted using SPSS software, version 14.5. The mean follow-up period was 53 months (range 12-97, SD19.9). Ninety five tumours were high grade (44%) and 84 tumours exhibited comedo necrosis (39%). The closest mean initial excision margin was 2.4 mm (range 0-22 mm, standard deviation 2.8) and a total of 72 tumours (33%) underwent further re-excision. The observed and the actuarial 8 year disease-free survival rates in this study were 91% and 83% respectively. The VNPI score and the presence of comedo necrosis were the only statistically significant prognostic indicators (P < 0.05). This follow-up study of 215 patients with DCIS treated with local excision and observation alone is one of the largest series in which rates of recurrence are unaffected by radiation therapy, hormone manipulation or chemotherapy. It has afforded us the opportunity to assess the prognostic impact of patient and tumour characteristics free of any potentially confounding treatment related influences. The results suggest that the VNPI can be used to identify a subset of patients who are at risk of local recurrence and who may potentially benefit from RT.Keywords
This publication has 19 references indexed in Scilit:
- Ductal Carcinoma In Situ: Biology, Diagnosis, and New TherapiesClinical Breast Cancer, 2007
- Radiation Therapy for Ductal Carcinoma In Situ: Is It Really Worth It?Journal of Clinical Oncology, 2007
- Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy?Journal of Surgical Oncology, 2007
- Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy?Journal of Surgical Oncology, 2006
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy GroupJournal of Clinical Oncology, 2006
- The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breastCancer, 2004
- Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trialThe Lancet, 2003
- Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experienceSeminars in Oncology, 2001
- Findings From 752 081 Clinical Breast Examinations Reported to a National Screening Program From 1995 Through 1998JNCI Journal of the National Cancer Institute, 2000
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992